K C Gorson

Summary

Country: USA

Publications

  1. ncbi request reprint Approach to neuromuscular disorders in the intensive care unit
    Kenneth C Gorson
    Neuromuscular Service, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    Neurocrit Care 3:195-212. 2005
  2. ncbi request reprint Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial
    Kenneth C Gorson
    Department of Neurology, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts 02135, USA
    Muscle Nerve 35:66-9. 2007
  3. doi request reprint Chronic inflammatory demyelinating polyneuropathy
    Kenneth C Gorson
    Neuromuscular Service, Tufts University School of Medicine, St Elizabeth s Medical Center, 736 Cambridge Street, Boston, MA 02135, USA Electronic address
    Neurol Clin 31:511-32. 2013
  4. doi request reprint Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
    Kenneth C Gorson
    Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    J Peripher Nerv Syst 15:326-33. 2010
  5. doi request reprint Acute brachial diplegia due to Lyme disease
    Kenneth C Gorson
    St Elizabeth s Medical Center, Tufts University School of Medicine Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02135, USA
    Neurologist 17:24-7. 2011
  6. ncbi request reprint Non-length dependent small fibre neuropathy/ganglionopathy
    K C Gorson
    Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
    J Neurol Neurosurg Psychiatry 79:163-9. 2008
  7. ncbi request reprint Vasculitic neuropathies: an update
    Kenneth C Gorson
    Tufts University School of Medicine, Boston, Massachusetts, USA
    Neurologist 13:12-9. 2007
  8. pmc Additional causes for distal sensory polyneuropathy in diabetic patients
    K C Gorson
    Department of Neurology, St Elizabeth s Medical Center, 736 Cambridge Street, Boston, MA 02135, USA
    J Neurol Neurosurg Psychiatry 77:354-8. 2006
  9. ncbi request reprint Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy
    Kenneth C Gorson
    Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    Neurology 63:715-7. 2004
  10. ncbi request reprint Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy
    K C Gorson
    Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts 02135, USA
    Muscle Nerve 24:778-86. 2001

Detail Information

Publications21

  1. ncbi request reprint Approach to neuromuscular disorders in the intensive care unit
    Kenneth C Gorson
    Neuromuscular Service, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    Neurocrit Care 3:195-212. 2005
    ....
  2. ncbi request reprint Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial
    Kenneth C Gorson
    Department of Neurology, Caritas St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts 02135, USA
    Muscle Nerve 35:66-9. 2007
    ..There was no improvement in secondary endpoints. No adverse events occurred. In this small prospective study, rituximab did not reduce IVIg requirements in the majority of patients with IVIg-dependent, immune-mediated polyneuropathies...
  3. doi request reprint Chronic inflammatory demyelinating polyneuropathy
    Kenneth C Gorson
    Neuromuscular Service, Tufts University School of Medicine, St Elizabeth s Medical Center, 736 Cambridge Street, Boston, MA 02135, USA Electronic address
    Neurol Clin 31:511-32. 2013
    ..Approximately 85% to 90% of patients eventually improve or stabilize with treatment, and the long-term prognosis of CIDP is favorable...
  4. doi request reprint Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice
    Kenneth C Gorson
    Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    J Peripher Nerv Syst 15:326-33. 2010
    ..0001). The CDAS is considered a simple and reproducible tool to classify patients with CIDP according to disease activity and treatment status that can be applied easily in practice and potentially to select patients for clinical trials...
  5. doi request reprint Acute brachial diplegia due to Lyme disease
    Kenneth C Gorson
    St Elizabeth s Medical Center, Tufts University School of Medicine Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02135, USA
    Neurologist 17:24-7. 2011
    ..to describe acute brachial diplegia as the initial manifestation of Lyme disease...
  6. ncbi request reprint Non-length dependent small fibre neuropathy/ganglionopathy
    K C Gorson
    Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
    J Neurol Neurosurg Psychiatry 79:163-9. 2008
    ..To describe the clinical and laboratory features of a painful non-length dependent, small fibre ganglionopathy (SFG)...
  7. ncbi request reprint Vasculitic neuropathies: an update
    Kenneth C Gorson
    Tufts University School of Medicine, Boston, Massachusetts, USA
    Neurologist 13:12-9. 2007
    ..These conditions are defined pathologically by tissue biopsy demonstrating disruption or destruction of the vessel wall with inflammatory cell infiltrates...
  8. pmc Additional causes for distal sensory polyneuropathy in diabetic patients
    K C Gorson
    Department of Neurology, St Elizabeth s Medical Center, 736 Cambridge Street, Boston, MA 02135, USA
    J Neurol Neurosurg Psychiatry 77:354-8. 2006
    ..To assess the frequency of additional causes of distal sensory polyneuropathy (DSP) in patients with diabetes mellitus (DM)...
  9. ncbi request reprint Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy
    Kenneth C Gorson
    Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    Neurology 63:715-7. 2004
    ..The authors found that MMF induced a modest benefit in ~20% of their patients and stabilized patient condition, allowing reduction of steroid or IVIg therapy...
  10. ncbi request reprint Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy
    K C Gorson
    Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts 02135, USA
    Muscle Nerve 24:778-86. 2001
    ..There were no clinical or electrodiagnostic features associated with a treatment response, nor did a reduction of the anti-MAG antibody titer correlate with clinical improvement...
  11. ncbi request reprint Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy
    K C Gorson
    Division of Neurology, St Elizabeth s Medical Center, 736 Cambridge Street, Boston, Massachusetts 02135, USA
    Muscle Nerve 23:37-43. 2000
    ..These differences most likely reflect the additive effects of superimposed diabetic axonal polyneuropathy in patients who develop CIDP...
  12. ncbi request reprint Clinical features, evaluation, and treatment of patients with polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS)
    K C Gorson
    Neurology Service, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
    J Clin Apher 14:149-53. 1999
    ..In addition to plasma exchange, chlorambucil, and cyclophosphamide, interferon-alpha is a novel therapy that holds promise for patients with IgM neuropathies associated with anti-myelin associated antibodies...
  13. ncbi request reprint Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders
    J A Grillo
    Division of Neurology, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA
    Neurology 57:1699-701. 2001
    ..Fourteen of 17 patients (82%) receiving maintenance therapy preferred rapid IVIg infusion because of its convenience. Rapid-infusion IVIg can be given safely and conveniently in many patients with neuromuscular disorders...
  14. ncbi request reprint Nonpoliovirus poliomyelitis simulating Guillain-Barré syndrome
    K C Gorson
    Division of Neurology, St Elizabeth s Medical Center, 736 Cambridge St, Boston, MA 02135, USA
    Arch Neurol 58:1460-4. 2001
    ....
  15. doi request reprint Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy
    R A C Hughes
    Department of Neurology, St Elizabeth s Medical Center, 736 Cambridge Street, Boston, MA 02135, USA
    Neurology 74:651-7. 2010
    ..Because IM interferon beta-1a (IM IFNbeta-1a) is an effective and safe treatment for MS, we conducted a dose-ranging efficacy study of IFNbeta-1a in patients with CIDP...
  16. doi request reprint Influence of critical illness on axonal loss in Guillain-Barré syndrome
    Doreen Ho
    Department of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02135, USA
    Muscle Nerve 39:10-5. 2009
    ..11), in the ICU (26 vs. 15), and in the hospital (29 vs. 18). Sixty-eight percent of patients with GBS in the ICU developed axon loss, but this was not related to the usual precipitants of CIP...
  17. ncbi request reprint Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy
    Lloyd Williams
    Tufts University School of Medicine, Boston, MA 02135, USA
    Obstet Gynecol 109:561-3. 2007
    ..Corticosteroids are a standard treatment for dermatomyositis in pregnancy, but they have adverse effects. Intravenous immune globulin is an effective therapy for this condition and may have few adverse effects...
  18. ncbi request reprint Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy
    Kenneth C Gorson
    Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge St, Boston, MA 02135, USA
    Arch Neurol 59:766-72. 2002
    ..Plasma exchange has been shown to be effective but alternative therapies have not been systematically evaluated...
  19. doi request reprint Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial
    Allan H Ropper
    Department of Neurology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Ann Neurol 65:386-93. 2009
    ..Randomized, blinded trial of intramuscular gene transfer using plasmid vascular endothelial growth factor (VEGF) to treat diabetic polyneuropathy...
  20. ncbi request reprint Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications
    Kenneth C Gorson
    Division of Neurology, St Elizabeth s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts 02135, USA
    Muscle Nerve 28:553-60. 2003
    ..ataxic neuropathy is uncommon; and (4). the lack of sicca symptoms or anti-SSA or SSB antibodies in patients with neuropathy does not exclude Sjögren syndrome based upon salivary gland pathology...
  21. ncbi request reprint The use of complementary and alternative medicines by patients with peripheral neuropathy
    Brian Brunelli
    Division of Neurology, St Elizabeth s Medical Center, 736 Cambridge Street, Boston, MA 02135, USA
    J Neurol Sci 218:59-66. 2004
    ..CAM users were better educated than nonusers, but most did not discuss CAM treatments with their physician. Neuropathic pain was substantially more common in CAM users, and lack of pain control was the most common reason for CAM use...